HYPOLIPIDEMIC ACTIVITY OF MEDOSTATIN IN PATIENTS WITH CORONARY HEART DISEASE IN DIFFERENT TYPES OF DYSLIPIDEMIA
https://doi.org/10.51523/2708-6011.2006-3-4-14
Abstract
Main aim of given study was comparison of effect of 20 mg/day of medostatin on level of lipids in different types of dyslipidemia - isoloted hypercholesterolemia and combined hyperlipidemia in patient with coronary heart disease. It was noted that 6 months therapy with medostatin exerted positive effect on blood lipid spectrum in both types of dyslipidemia.
References
1. Перова, Н. В. Нарушения липидного обмена, их динамика и коррекция: в кн. Кардиология. Руководство для врачей под рук. Р. Г. Оганова и И. Г. Фоминой. - М. :Медицина, 2004. - С. 54-101.
2. Bradford, R. H. Expanded Clinical Evaluation of Lovastatin [Exel] Study : design and patient characteristics of a double-blind placebo-controlled study on patients with moderate hypercholesterolemia / R. H. Bradford [et al.] // AM J Cardiol. -1990. - Vol. 66. - P. 44-55.
3. Friedwald, W. Estimation of the LDL cholesterol in plasma without use of the preperative ultrasentrifuge / W. Friedwald, R. Levy, D. Fredricson // Clin Chem. -1972. - Vol. 18. - P. 49-502.
4. Климов, А.М. Оценка липидных показателей и индексов при ишемической болезни сердца / А. М. Климов, А. Д. Деев, Д. В. Шестов // Кардиология. - 1983. - № 10. - С. 82-83.
Review
For citations:
Siluyanov V.V. HYPOLIPIDEMIC ACTIVITY OF MEDOSTATIN IN PATIENTS WITH CORONARY HEART DISEASE IN DIFFERENT TYPES OF DYSLIPIDEMIA. Health and Ecology Issues. 2006;(4):76-80. (In Russ.) https://doi.org/10.51523/2708-6011.2006-3-4-14
Views: 211
Email this article 